PDF herunterladen
Dtsch Med Wochenschr 2014; 139(39): 1932-1936
DOI: 10.1055/s-0034-1387285
Aktuelle Diagnostik & Therapie | Review article
Kardiologie
© Georg Thieme Verlag KG Stuttgart · New York

Prognostische Implikation und Strategien zur Vermeidung von ICD-Schocks

Prognostic implications and strategies to avoid ICD shocks
F. W. Horlbeck
1   Medizinische Klinik II, Kardiologie, Angiologie, Pneumologie und Intensivmedizin – Universitätsklinikum Bonn
,
G. Nickenig
1   Medizinische Klinik II, Kardiologie, Angiologie, Pneumologie und Intensivmedizin – Universitätsklinikum Bonn
,
J. O. Schwab
1   Medizinische Klinik II, Kardiologie, Angiologie, Pneumologie und Intensivmedizin – Universitätsklinikum Bonn
› Institutsangaben
Weitere Informationen

Publikationsverlauf

11. Juli 2014

21. August 2014

Publikationsdatum:
16. September 2014 (online)

Auch verfügbar auf
    Lizenzen und Reprints

Schlüsselwörter

implantierbarer Kardioverter/Defibrillator - Programmierung - Schockvermeidung - ventrikuläre Tachykardie - Kammerflimmern - Prognose

Keywords

implantable cardioverter/ defibrillator - programming - shock reduction - ventricular tachycardia - ventricular fibrillation - prognosis
 

  • Literatur

  • 1 Almendral J, Arribas F, Wolpert C et al. Dual-chamber defibrillators reduce clinically significant adverse events compared with single-chamber devices: results from the DATAS (Dual chamber and Atrial Tachyarrhythmias Adverse events Study) trial. Europace 2008; 10: 528-535
    CrossrefPubMedGoogle Scholar
  • 2 Bourke JP, Turkington D, Thomas G et al. Florid psychopathology in patients receiving shocks from implanted cardioverter-defibrillators. Heart 1997; 78: 581-583
    CrossrefPubMedGoogle Scholar
  • 3 Daubert JP, Zareba W, Cannom DS et al. Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact. J Am Coll Cardiol 2008; 51: 1357-1365
    CrossrefPubMedGoogle Scholar
  • 4 Dewland TA, Pellegrini CN, Wang Y et al. Dual-chamber implantable cardioverter-defibrillator selection is associated with increased complication rates and mortality among patients enrolled in the NCDR implantable cardioverter-defibrillator registry. J Am Coll Cardiol 2011; 58: 1007-1013
    CrossrefPubMedGoogle Scholar
  • 5 Friedman PA, Bradley D, Koestler C et al. A prospective randomized trial of single- or dual-chamber implantable cardioverter-defibrillators to minimize inappropriate shock risk in primary sudden cardiac death prevention. Europace 2014; DOI: 10.1093/europace/euu022.
    PubMedGoogle Scholar
  • 6 Friedman PA, McClelland RL, Bamlet WR et al. Dual-chamber versus single-chamber detection enhancements for implantable defibrillator rhythm diagnosis: the detect supraventricular tachycardia study. Circulation 2006; 113: 2871-2879
    CrossrefPubMedGoogle Scholar
  • 7 Gasparini M, Anselme F, Clementy J et al. BIVentricular versus right ventricular antitachycardia pacing to terminate ventricular tachyarrhythmias in patients receiving cardiac resynchronization therapy: the ADVANCE CRT-D Trial. Am Heart J 2010; 159: 1116-1123 e1112
    CrossrefPubMedGoogle Scholar
  • 8 Gasparini M, Menozzi C, Proclemer A et al. A simplified biventricular defibrillator with fixed long detection intervals reduces implantable cardioverter defibrillator (ICD) interventions and heart failure hospitalizations in patients with non-ischaemic cardiomyopathy implanted for primary prevention: the RELEVANT [Role of long dEtection window programming in patients with LEft VentriculAr dysfunction, Non-ischemic eTiology in primary prevention treated with a biventricular ICD] study. Eur Heart J 2009; 30: 2758-2767
    CrossrefPubMedGoogle Scholar
  • 9 Gasparini M, Proclemer A, Klersy C et al. Effect of long-detection interval vs standard-detection interval for implantable cardioverter-defibrillators on antitachycardia pacing and shock delivery: the ADVANCE III randomized clinical trial. JAMA 2013; 309: 1903-1911
    CrossrefPubMedGoogle Scholar
  • 10 Germano JJ, Reynolds M, Essebag V et al. Frequency and causes of implantable cardioverter-defibrillator therapies: is device therapy proarrhythmic?. Am J Cardiol 2006; 97: 1255-1261
    CrossrefPubMedGoogle Scholar
  • 11 Gilliam FR, Hayes DL, Boehmer JP et al. Real world evaluation of dual-zone ICD and CRT-D programming compared to single-zone programming: the ALTITUDE REDUCES study. J Cardiovasc Electrophysiol 2011; 22: 1023-1029
    CrossrefPubMedGoogle Scholar
  • 12 Gulizia MM, Piraino L, Scherillo M et al. A randomized study to compare ramp versus burst antitachycardia pacing therapies to treat fast ventricular tachyarrhythmias in patients with implantable cardioverter defibrillators: the PITAGORA ICD trial. Circ Arrhythm Electrophysiol 2009; 2: 146-153
    CrossrefPubMedGoogle Scholar
  • 13 Kolb C, Sturmer M, Sick P et al. Reduced risk of inappropriate ICD shocks with dual-chamber therapy compared with single-chamber therapy – results of the randomized OPTION study. JACC Heart Failure 2014; in press 2014
    PubMedGoogle Scholar
  • 14 Leenhardt A, Defaye P, Mouton E et al. First inappropriate implantable cardioverter defibrillator therapy is often due to inaccurate device programming: analysis of the French OPERA registry. Europace 2012; 14: 1465-1474
    CrossrefPubMedGoogle Scholar
  • 15 Mark DB, Anstrom KJ, Sun JL et al. Quality of life with defibrillator therapy or amiodarone in heart failure. N Engl J Med 2008; 359: 999-1008
    CrossrefPubMedGoogle Scholar
  • 16 Martins RP, Blangy H, Muresan L et al. Safety and efficacy of programming a high number of antitachycardia pacing attempts for fast ventricular tachycardia: a prospective study. Europace 2012; 14: 1457-1464
    CrossrefPubMedGoogle Scholar
  • 17 Moss AJ, Schuger C, Beck CA et al. Reduction in inappropriate therapy and mortality through ICD programming. N Engl J Med 2012; 367: 2275-2283
    CrossrefPubMedGoogle Scholar
  • 18 Peterson PN, Varosy PD, Heidenreich PA et al. Association of single- vs dual-chamber ICDs with mortality, readmissions, and complications among patients receiving an ICD for primary prevention. JAMA 2013; 309: 2025-2034
    CrossrefPubMedGoogle Scholar
  • 19 Poole JE, Johnson GW, Hellkamp AS et al. Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med 2008; 359: 1009-1017
    CrossrefPubMedGoogle Scholar
  • 20 Raitt MH. Implantable cardioverter-defibrillator shocks: a double-edged sword?. J Am Coll Cardiol 2008; 51: 1366-1368
    CrossrefPubMedGoogle Scholar
  • 21 Ruwald AC, Sood N, Ruwald MH et al. Frequency of inappropriate therapy in patients implanted with dual- versus single-chamber ICD devices in the ICD arm of MADIT-CRT. J Cardiovasc Electrophysiol 2013; 24: 672-679
    CrossrefPubMedGoogle Scholar
  • 22 Saeed M, Hanna I, Robotis D et al. Programming implantable cardioverter-defibrillators in patients with primary prevention indication to prolong time to first shock: results from the PROVIDE study. J Cardiovasc Electrophysiol 2014; 25: 52-59
    CrossrefPubMedGoogle Scholar
  • 23 Santini M, Lunati M, Defaye P et al. Prospective multicenter randomized trial of fast ventricular tachycardia termination by prolonged versus conventional anti-tachyarrhythmia burst pacing in implantable cardioverter-defibrillator patients-Atp DeliVery for pAiNless ICD thErapy (ADVANCE-D) Trial results. J Interv Card Electrophysiol 2010; 27: 127-135
    CrossrefPubMedGoogle Scholar
  • 24 Schwab J et al. First results of the ATPonFastVT-study. Heart Rhythm 2011; 8 (Suppl. 05) P06-16
    PubMedGoogle Scholar
  • 25 Schwab JO. Antitachycardia pacing to terminate ventricular tachyarrhythmia: new insights into how to reduce painful implantable cardioverter defibrillator shocks. Europace 2012; 14: 1381-1382
    CrossrefPubMedGoogle Scholar
  • 26 Schwab JO, Bonnemeier H, Kleemann T et al. Reduction of inappropriate ICD therapies in patients with primary prevention of sudden cardiac death: DECREASE-study. AHA 2013; Late breaking Trials
    PubMedGoogle Scholar
  • 27 Sweeney MO, Sherfesee L, DeGroot PJ et al. Differences in effects of electrical therapy type for ventricular arrhythmias on mortality in implantable cardioverter-defibrillator patients. Heart Rhythm 2010; 7: 353-360
    CrossrefPubMedGoogle Scholar
  • 28 Theuns DA, Rivero-Ayerza M, Boersma E et al. Prevention of inappropriate therapy in implantable defibrillators: A meta-analysis of clinical trials comparing single-chamber and dual-chamber arrhythmia discrimination algorithms. Int J Cardiol 2008; 125: 352-357
    CrossrefPubMedGoogle Scholar
  • 29 van Rees JB, Borleffs CJ, de Bie MK et al. Inappropriate implantable cardioverter-defibrillator shocks: incidence, predictors, and impact on mortality. J Am Coll Cardiol 2011; 57: 556-562
    CrossrefPubMedGoogle Scholar
  • 30 Wathen MS, DeGroot PJ, Sweeney MO et al. Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators: Pacing Fast Ventricular Tachycardia Reduces Shock Therapies (PainFREE Rx II) trial results. Circulation 2004; 110: 2591-2596
    CrossrefPubMedGoogle Scholar
  • 31 Wathen MS, Sweeney MO, DeGroot PJ et al. Shock reduction using antitachycardia pacing for spontaneous rapid ventricular tachycardia in patients with coronary artery disease. Circulation 2001; 104: 796-801
    CrossrefPubMedGoogle Scholar
  • 32 Weiss R, Knight BP, Gold MR et al. Safety and efficacy of a totally subcutaneous implantable-cardioverter defibrillator. Circulation 2013; 128: 944-953
    CrossrefPubMedGoogle Scholar
  • 33 Wilkoff BL, Cook JR, Epstein AE et al. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial. JAMA 2002; 288: 3115-3123
    CrossrefPubMedGoogle Scholar
  • 34 Wilkoff BL, Williamson BD, Stern RS et al. Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study. J Am Coll Cardiol 2008; 52: 541-550
    CrossrefPubMedGoogle Scholar